JATT Acquisition Corp Contracts & Agreements
73 Contracts & Agreements
- Business Finance (38 contracts)
- Business Operations (6)
- Human Resources (4)
- Intellectual Property (2)
- Mergers & Acquisitions (3)
- Uncategorized (20)
- Tender and Support Agreement, dated as of July 11, 2024, by and among Zura Bio Limited, and the warrant holders party thereto (Filed With SEC on July 12, 2024)
- Dealer Manager Agreement, dated as of July 11, 2024 by and between Zura Bio Limited and Cantor Fitzgerald & Co., as dealer manager (Filed With SEC on July 12, 2024)
- Form of Subscription Agreement (Filed With SEC on April 23, 2024)
- Form of Pre-Funded Warrant to purchase Ordinary Shares (Filed With SEC on April 23, 2024)
- Description of registrant's securities (Filed With SEC on March 28, 2024)
- Employment Agreement between Zura Bio Limited and Robert Lisicki (Filed With SEC on January 8, 2024)
- Service Agreement between Zura Bio Limited and Kiran Nistala (Filed With SEC on December 6, 2023)
- Offer Letter Agreement with Kim Davis, dated November 22, 2022 (Filed With SEC on August 11, 2023)
- License, Development and Commercialization Agreement between ZB17 LLCand Eli Lilly and Company, dated April 26, 2023 (Filed With SEC on August 11, 2023)
- Zura Bio Limited 2023 Equity Incentive Plan, as amended (Filed With SEC on June 2, 2023)
- Offer Letter, dated March 2, 2023, to Amit Munshi (Filed With SEC on May 12, 2023)
- Form of Subscription Agreement (Filed With SEC on May 3, 2023)
- Form of Pre-Funded Warrant to Purchase Ordinary Shares (Filed With SEC on May 3, 2023)
- Service Agreement, dated as of April 7, 2023, by and between the Company and Verender Badial (Filed With SEC on April 10, 2023)
- Service Agreement, dated as of April 7, 2023, by and between the Company and Dr. Someit Sidhu (Filed With SEC on April 10, 2023)
- Severance and General Release Agreement, dated April 7, 2023, by and between Zura Bio Limited and Preston Klassen (Filed With SEC on April 7, 2023)
- Side Letter to Amended and Restated Forward Purchase Agreement, dated as of March 23, 2023, by and among the Company and the FPA Investors (Filed With SEC on March 28, 2023)
- Subscription Agreement, dated as of March 13, 2023, by and between JATT Acquisition Corp and Eugene Investment & Securities Co., Ltd (Filed With SEC on March 24, 2023)
- Amended and Restated Registration Rights Agreement dated March 20, 2023, by and among Zura Bio Limited and the other parties signatories thereto (Filed With SEC on March 24, 2023)
- Zura Bio Limited 2023 Equity Incentive Plan (Filed With SEC on March 24, 2023)
- Zura Bio Limited 2023 Employee Stock Purchase Plan (Filed With SEC on March 24, 2023)
- Form of Indemnity Agreement of Zura Bio Limited (Filed With SEC on March 24, 2023)
- Lock-Up Agreement, dated as of March 20, 2023, by and between JATT Acquisition Corp and Eli Lilly and Company (Filed With SEC on March 24, 2023)
- Amendment No. 2 to the Forward Purchase Agreement and Related Agreements, dated as of March 8, 2023, among JATT Acquisition Corp, Athanor Master Fund, LP, and Athanor... (Filed With SEC on March 10, 2023)
- Third Amendment to Business Combination Agreement dated January 16, 2023, by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd and Zura... (Filed With SEC on January 19, 2023)
- Equity Grant Agreement, dated as of December 8, 2022, by and between JATT Acquisition Corp and Eli Lilly and Company (Filed With SEC on December 12, 2022)
- Second Amendment to Business Combination Agreement, dated as of November 14, 2022, by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd.... (Filed With SEC on November 15, 2022)
- Sponsor Forfeiture Agreement dated June 16, 2022 (Filed With SEC on August 22, 2022)
- Share Option Agreement between Zura Bio Limited and Sandeep Kulkarni, dated June 8, 2022 (Filed With SEC on August 22, 2022)
- License Agreement between Zura Bio Limited and Pfizer Inc., dated March 22, 2022 (Filed With SEC on August 22, 2022)
- Investment Agreement between Hana Immunotherapeutics LLC and Zura Bio, Ltd., dated February 20, 2022 (Filed With SEC on August 22, 2022)
- Form of Indemnity Agreement (Filed With SEC on August 22, 2022)
- Specimen Warrant Certificate of New JATT (Filed With SEC on August 22, 2022)
- Specimen Share Certificate of New JATT (Filed With SEC on August 22, 2022)
- Form of Amended and Restated Registration Rights Agreement (Filed With SEC on June 17, 2022)
- Amendment to the Insider Letter Agreement, dated June 16, 2022 (Filed With SEC on June 17, 2022)
- Lock-Up Agreement, dated as of June 16, 2022 (Filed With SEC on June 17, 2022)
- Sponsor Forfeiture Agreement, dated as of June 16, 2022 (Filed With SEC on June 17, 2022)
- Company Support Agreement, dated as of June 16, 2022 (Filed With SEC on June 17, 2022)
- Sponsor Support Agreement, dated as of June 16, 2022 (Filed With SEC on June 17, 2022)
- PIPE Subscription Agreement, dated as of June 16, 2022 (Filed With SEC on June 17, 2022)
- Business Combination Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd. and Zura Bio Limited (Filed With SEC on June 17, 2022)
- Working Capital Promissory Note dated May 11, 2022 (Filed With SEC on May 13, 2022)
- Amended Forward Purchase Agreement dated January 27, 2022 by and between Athanor Master Fund, LP, Athanor International Master Fund LP and the Registrant (Filed With SEC on April 11, 2022)
- Forward Purchase Agreement between the Registrant and Athanor Master Fund, LP dated August 5, 2021 (Filed With SEC on November 19, 2021)
- Forward Purchase Agreement between the Registrant and Athanor International Master Fund, LP dated August 5, 2021 (Filed With SEC on November 19, 2021)
- Administrative Services Agreement, dated July 13, 2021, by and between the Company and the Sponsor (Filed With SEC on July 19, 2021)
- Underwriting Agreement, dated July 13, 2021, by and between the Company and Raymond James & Associates, Inc., as representative of the underwriters (Filed With SEC on July 19, 2021)
- Warrant Agreement, dated as of July 16, 2021, by and between the Company and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on July 19, 2021)
- Letter Agreements, dated July 13, 2021, by and among the Company and its officers, directors, the Sponsor and the other parties named therein (Filed With SEC on July 19, 2021)
- Investment Management Trust Agreement, dated as of July 16, 2021, by and between the Company and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on July 19, 2021)
- Registration and Shareholder Rights Agreement, dated as of July 13 2021, by and among the Company, the Sponsor and certain security holders (Filed With SEC on July 19, 2021)
- Indemnification Agreements, each dated as of July 13, 2021, by and between the Company and each of the officers and directors of the Company (Filed With SEC on July 19, 2021)
- Private Placement Warrants Purchase Agreement, dated as of July 13, 2021, by and between the Company and the Sponsor (Filed With SEC on July 19, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the sponsor (Filed With SEC on July 6, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on July 6, 2021)
- Form of Letter Agreement among the Registrant and our officers directors and sponsor (Filed With SEC on July 6, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on July 6, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 15, 2021)
- JATT AcquisitionCorp. c/o Maples Corporate ServicesLimited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, CaymanIslands (Filed With SEC on June 15, 2021)
- Form of Indemnity Agreement (Filed With SEC on June 15, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the sponsor (Filed With SEC on June 15, 2021)
- Securities Subscription Agreement, dated March 22, 2021 between the Registrant and the sponsor (Filed With SEC on June 15, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on June 15, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on June 15, 2021)
- Form of Administrative Service Agreement between the Registrant and the sponsor (Filed With SEC on June 15, 2021)
- Promissory Note dated March 22, 2021 issued to the sponsor (Filed With SEC on June 15, 2021)
- Form of Letter Agreement among the Registrant and our officers directors and sponsor (Filed With SEC on June 15, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on June 15, 2021)
- Specimen Warrant Certificate (Filed With SEC on June 15, 2021)
- Specimen Class A Ordinary Share Certificate (Filed With SEC on June 15, 2021)
- Specimen Unit Certificate (Filed With SEC on June 15, 2021)
